Senators who led pharma-friendly patent reform also prime targets for pharma cash— Red T Raccoon (@RedTRaccoon) March 24, 2020
Sen. Thom Tillis received more than $156,000 from political action committees tied to drug manufacturers in 2019, more than any other member of Congress.#OneTermThomhttps://t.co/syu0rxCi5m
Tuesday, March 24, 2020
Senators who led pharma-friendly patent reform also prime targets for pharma cash Sen. Thom Tillis received more than $156,000 from political action committees tied to drug manufacturers in 2019, more than any other member of Congress
